32 results on '"Koumpouras, Fotios"'
Search Results
2. High-throughput identification of autoantibodies that target the human exoproteome
3. Obexelimab in Systemic Lupus Erythematosus With Exploration of Response Based on Gene Pathway Co‐Expression Patterns: A Double‐Blind, Randomized, Placebo‐Controlled, Phase 2 Trial
4. Randomized, Double‐Blind, Placebo‐Controlled Trial of the Effect of Vitamin D3 on the Interferon Signature in Patients With Systemic Lupus Erythematosus
5. Contributors
6. Chemical Camouflage of Antigenic Determinants: Stealth Erythrocytes
7. Vascular-Targeted Therapy for Systemic Lupus Erythematosus–Associated Vasculitis
8. Evaluating the risk of QTc prolongation associated with hydroxychloroquine use with antidepressants in lupus patients with fibromyalgia
9. Chapter 11 - Interferons and cytokines in SLE pathogenesis and therapy
10. Type 1 interferon activated STAT4 regulates T follicular helper (Tfh)-cell dependent cytokine and immunoglobulin production in lupus
11. REAP: A platform to identify autoantibodies that target the human exoproteome
12. Type I Interferon–Activated STAT4 Regulation of Follicular Helper T Cell–Dependent Cytokine and Immunoglobulin Production in Lupus
13. Sjögren Syndrome
14. Rheumatic Manifestations of Systemic Disorders
15. Lead Authors and Contributors
16. IL-7 receptor alpha defines heterogeneity and signature of human effector memory CD8+ T cells in high dimensional analysis
17. Stand Together and Deliver: Challenges and Opportunities for Rheumatology Education During the COVID ‐19 Pandemic
18. Defining heterogeneity and biological signature in human effector memory CD8+ T cells expressing different levels of IL-7 receptor alpha by high-dimensional analysis
19. Effects of a Novel Tylophorine Analog on Collagen-Induced Arthritis Through Inhibition of the Innate Immune Response
20. FRI0176 PHASE 2, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF A REVERSIBLE B CELL INHIBITOR, XMAB®5871, IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
21. 98 Results of a phase 2, double-blind, randomized, placebo-controlled study of a reversible B cell inhibitor, XmAb®5871, in systemic lupus erythematosus (SLE)
22. Double-Blind Randomized Placebo-Controlled Trial of the Effect of Vitamin D3 on the Interferon Signature in Patients with Systemic Lupus Erythematosus
23. Randomized, Double-Blind, Placebo-Controlled Trial of the Effect of Vitamin D3on the Interferon Signature in Patients With Systemic Lupus Erythematosus
24. 133 Hydroxychloroquine-Induced Lipidosis: Boon for Lupus Nephritis Becomes Bane
25. Randomized, Double-Blind, Placebo-Controlled Trial of the Effect of Vitamin D3 on the Interferon Signature in Patients With Systemic Lupus Erythematosus.
26. Antigenic Modulation of Erythrocytes: Possible Applications to Transfusion Medicine. ♦ 670
27. Chapter 85 - Sjögren Syndrome
28. Chapter 90 - Rheumatic Manifestations of Systemic Disorders
29. Lead Authors and Contributors
30. Outcomes following total shoulder arthroplasty in patients with systemic lupus erythematosus.
31. A dual-acting DNASE1/DNASE1L3 biologic prevents autoimmunity and death in genetic and induced lupus models.
32. IL-7 receptor alpha defines heterogeneity and signature of human effector memory CD8 + T cells in high dimensional analysis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.